Compare ECOR & FGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECOR | FGNX |
|---|---|---|
| Founded | 2005 | 1932 |
| Country | United States | United States |
| Employees | N/A | 15 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 44.1M |
| IPO Year | 2018 | N/A |
| Metric | ECOR | FGNX |
|---|---|---|
| Price | $7.06 | $6.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $18.00 | ★ $35.00 |
| AVG Volume (30 Days) | 52.1K | ★ 65.4K |
| Earning Date | 05-06-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,032,000.00 | N/A |
| Revenue This Year | $33.60 | $650.31 |
| Revenue Next Year | $30.40 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.20 | N/A |
| 52 Week Low | $4.16 | $1.59 |
| 52 Week High | $8.30 | $18.42 |
| Indicator | ECOR | FGNX |
|---|---|---|
| Relative Strength Index (RSI) | 62.81 | 48.80 |
| Support Level | $4.55 | $5.43 |
| Resistance Level | $7.50 | $6.36 |
| Average True Range (ATR) | 0.48 | 0.39 |
| MACD | 0.08 | -0.05 |
| Stochastic Oscillator | 87.25 | 19.30 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.